Global Nuclear Imaging Market 2017-2021

Overview of the global nuclear imaging market

Research analysis on the global nuclear imaging market identifies that the major shift towards the hybrid nuclear imaging will be one of the major factors that will have a positive impact on the growth of the market. Technavio’s market research analysts predict that this market will grow at a CAGR of more than 6% by 2021. Hybrid imaging technology has many benefits such as early diagnosis, accurate disease staging, and effective response to the treatment of chronic conditions such as cancer. CT/MRI was integrated with positron emission tomography (PET) and single-photon emission computed tomography (SPECT) to perform improved nuclear imaging procedures and find the exact location of lesions and chronic disorders. Computed tomography (CT) improves the accuracy of PET and SPECT and enables the imaging of both functional and anatomical aspects of the human system.

The rising prevalence of chronic disorders such as cardiac, neurology, orthopedic, and other disorders is driving growth in the global nuclear imaging market in the Americas. This in turn, will boost the demand for nuclear imaging, especially hybrid imaging systems in the region. The market will continue to grow in the region during the estimated period because the majority of installations of PET/CT, SPECT/CT, PET/MRI, and SPECT/MRI systems are witnessed in the US.

Competitive landscape and key vendors